Hyaluronidase-fihj
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hyaluronidase-fihj, covering 2024-06-12 to 2024-06-12. Get the full timeline:
Most recent: Clinical Trial Update: Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm Study [NA]